Dr. Sarah Stabenfeldt, an Associate Professor of Biomedical Engineering in The School of Biological and Health Systems Engineering, and Dr. Rachael Sirianni, an Associate Professor in the Vivian L. Smith Department of Neurosurgery at the University of Texas Health Science Center at Houston, and Adjunct Faculty in the School of Biological and health Systems Engineering are leading the first exploration of sex-targeted drug delivery for traumatic brain injury.
Brain injury research explores sex-dependent therapeutics
